Inflation

A new report shows the Middle East conflict has triggered a three-year high in supply chain pressure, leading to soaring costs, shortages, and stockpiling.

Jetstream Venture Fund's deals with Surf Therapeutics and Hill Research signal a new era of accessible venture capital backing transformative technologies.

The packaging giant lowers its Q1 forecast, citing weather, geopolitics, and internal issues, while pushing a bold plan for long-term recovery.

Private equity giant Warburg Pincus is launching a dedicated fund, betting on Europe's rearmament and quest for strategic autonomy amid rising global tensions.

As Pool Corp preps its Q1 earnings, all eyes are on the distributor as a bellwether for consumer spending, industry health, and the backyard lifestyle trend.

A landmark partnership is tokenizing not just gold bars, but the very output of U.S. mines, offering investors a direct stake in physical production.

As Ibotta prepares its Q1 2026 report, investors weigh recent revenue dips against major new partnerships and a pivotal shift in business strategy.

An investigation into a Florida 'trash school' reveals a national crisis of toxic dumps near schools, disproportionately harming children of color.

New vehicle prices are soaring past $49,000, driven by big trucks and SUVs, while an EV price war makes electric models more affordable than ever.

An unlikely partnership between a rural church and a treatment center is bringing a mobile clinic to Western North Carolina, offering hope on the front lines.

Facing declining sales and an aging demographic, the iconic motorcycle maker launches 'RIDE,' a new global platform to reclaim its heritage for a new generation.

Activist investor Veradace Partners demands Repay scrap its KUBRA deal, alleging a breach of fiduciary duty and widespread shareholder opposition.

A stable year for Canada's West Coast ports masks urgent calls for federal action to prevent future supply chain chaos ahead of critical 2027 labor talks.

New data reveals a surge in mental health leaves despite corporate investment, exposing a costly 'silent burnout' crisis hiding in plain sight.

A new report reveals that where you live dictates your medical costs, with prices, not the care you use, driving a more than twofold spending gap.

A Swiss biotech's novel antibiotic has entered human trials with new funding, offering a fresh hope against the world's most dangerous superbugs.

Appliance giant Electrolux is set to release its Q1 results. Investors are watching to see if cost-cutting can overcome weak consumer demand.

A minority-owned firm revives a 1920s Santa Ana property with modern luxury, highlighting a trend of historic preservation amid gentrification concerns.

Brazilian importers bypass high local credit costs using a Chinese state-backed insurance, unlocking cash flow and fueling a new wave of trade growth.

Amid global volatility, B2PRIME Group announced record 2025 profits, a 5x surge in volume, and eliminated all debt, setting a new bar for resilience.